DoubleVerify Unveils Attention Offering for Publishers, Raising the Bar for Performance Optimization and Transparency
Half of the 2023 U.S. Pharmaceutical Launch Class Underperforms Pre-Launch First Year Forecasts but the Needle Is Moving
Rand Capital Reports 27% Increase in Total Investment Income for Third Quarter 2024, Supported by Strategic Debt Portfolio Growth